H7HLAII DNA Influenza Vaccine
Clinical trial NCT06046092 · UNKNOWN
Trial details
- NCT number
- NCT06046092
- Sponsor
- Oslo University Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-15
- Primary completion
- 2024-12-31
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.